With the aim of developing a valid and reliable in vitro and in vivo model for the investigation of the dual-tracer imaging concept, two PCa-associated targets, PSMA and GRPR, were chosen for a first proof-of-concept study. The gene discussed is FOLH1; the disease is posterior cortical atrophy.